- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 4 x CFF: CAFFEINE(Non-covalent)
CFF.2: 5 residues within 4Å:- Chain A: E.4242, I.4245, W.4714, I.4994, W.5009
3 PLIP interactions:3 interactions with chain A- pi-Stacking: A:W.4714, A:W.4714, A:W.4714
CFF.9: 5 residues within 4Å:- Chain F: E.4242, I.4245, W.4714, I.4994, W.5009
3 PLIP interactions:3 interactions with chain F- pi-Stacking: F:W.4714, F:W.4714, F:W.4714
CFF.16: 5 residues within 4Å:- Chain G: E.4242, I.4245, W.4714, I.4994, W.5009
3 PLIP interactions:3 interactions with chain G- pi-Stacking: G:W.4714, G:W.4714, G:W.4714
CFF.23: 5 residues within 4Å:- Chain H: E.4242, I.4245, W.4714, I.4994, W.5009
3 PLIP interactions:3 interactions with chain H- pi-Stacking: H:W.4714, H:W.4714, H:W.4714
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.3: 13 residues within 4Å:- Chain A: K.4214, K.4217, R.4218, M.4952, K.4955, C.4956, F.4957, I.4958, F.4973, T.4977, H.4981, N.4982, L.4983
10 PLIP interactions:10 interactions with chain A- Hydrogen bonds: A:F.4957, A:I.4958, A:H.4981, A:L.4983
- Salt bridges: A:K.4214, A:K.4214, A:K.4217, A:K.4217, A:K.4217, A:R.4218
ATP.5: 13 residues within 4Å:- Chain A: W.883, R.887, R.898, H.905, C.907, E.918, Y.921, N.922, M.925, H.994, W.997, R.1021, N.1036
11 PLIP interactions:11 interactions with chain A- Hydrogen bonds: A:N.922, A:H.994, A:R.1021, A:R.1021, A:N.1036
- Salt bridges: A:R.887, A:R.898, A:H.905
- pi-Stacking: A:W.997, A:W.997, A:W.997
ATP.10: 13 residues within 4Å:- Chain F: K.4214, K.4217, R.4218, M.4952, K.4955, C.4956, F.4957, I.4958, F.4973, T.4977, H.4981, N.4982, L.4983
10 PLIP interactions:10 interactions with chain F- Hydrogen bonds: F:F.4957, F:I.4958, F:H.4981, F:L.4983
- Salt bridges: F:K.4214, F:K.4214, F:K.4217, F:K.4217, F:K.4217, F:R.4218
ATP.12: 13 residues within 4Å:- Chain F: W.883, R.887, R.898, H.905, C.907, E.918, Y.921, N.922, M.925, H.994, W.997, R.1021, N.1036
11 PLIP interactions:11 interactions with chain F- Hydrogen bonds: F:N.922, F:H.994, F:R.1021, F:R.1021, F:N.1036
- Salt bridges: F:R.887, F:R.898, F:H.905
- pi-Stacking: F:W.997, F:W.997, F:W.997
ATP.17: 13 residues within 4Å:- Chain G: K.4214, K.4217, R.4218, M.4952, K.4955, C.4956, F.4957, I.4958, F.4973, T.4977, H.4981, N.4982, L.4983
10 PLIP interactions:10 interactions with chain G- Hydrogen bonds: G:F.4957, G:I.4958, G:H.4981, G:L.4983
- Salt bridges: G:K.4214, G:K.4214, G:K.4217, G:K.4217, G:K.4217, G:R.4218
ATP.19: 13 residues within 4Å:- Chain G: W.883, R.887, R.898, H.905, C.907, E.918, Y.921, N.922, M.925, H.994, W.997, R.1021, N.1036
11 PLIP interactions:11 interactions with chain G- Hydrogen bonds: G:N.922, G:H.994, G:R.1021, G:R.1021, G:N.1036
- Salt bridges: G:R.887, G:R.898, G:H.905
- pi-Stacking: G:W.997, G:W.997, G:W.997
ATP.24: 13 residues within 4Å:- Chain H: K.4214, K.4217, R.4218, M.4952, K.4955, C.4956, F.4957, I.4958, F.4973, T.4977, H.4981, N.4982, L.4983
10 PLIP interactions:10 interactions with chain H- Hydrogen bonds: H:F.4957, H:I.4958, H:H.4981, H:L.4983
- Salt bridges: H:K.4214, H:K.4214, H:K.4217, H:K.4217, H:K.4217, H:R.4218
ATP.26: 13 residues within 4Å:- Chain H: W.883, R.887, R.898, H.905, C.907, E.918, Y.921, N.922, M.925, H.994, W.997, R.1021, N.1036
11 PLIP interactions:11 interactions with chain H- Hydrogen bonds: H:N.922, H:H.994, H:R.1021, H:R.1021, H:N.1036
- Salt bridges: H:R.887, H:R.898, H:H.905
- pi-Stacking: H:W.997, H:W.997, H:W.997
- 4 x CA: CALCIUM ION(Non-covalent)
CA.4: 3 residues within 4Å:- Chain A: E.3896, E.3970, T.4999
2 PLIP interactions:2 interactions with chain A- Metal complexes: A:E.3970, A:T.4999
CA.11: 3 residues within 4Å:- Chain F: E.3896, E.3970, T.4999
2 PLIP interactions:2 interactions with chain F- Metal complexes: F:E.3970, F:T.4999
CA.18: 3 residues within 4Å:- Chain G: E.3896, E.3970, T.4999
2 PLIP interactions:2 interactions with chain G- Metal complexes: G:E.3970, G:T.4999
CA.25: 3 residues within 4Å:- Chain H: E.3896, E.3970, T.4999
2 PLIP interactions:2 interactions with chain H- Metal complexes: H:E.3970, H:T.4999
- 8 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PCW.6: 13 residues within 4Å:- Chain A: L.4848, Y.4849, V.4852, N.4855, F.4856, Y.4907, Y.4910, V.4913, F.4914, T.4917, F.4921
- Chain H: Y.4628
- Ligands: PCW.28
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:L.4848, A:Y.4849, A:Y.4849, A:Y.4849, A:V.4852, A:F.4856, A:F.4856, A:F.4856, A:Y.4907, A:Y.4910, A:Y.4910, A:V.4913, A:F.4921
PCW.7: 15 residues within 4Å:- Chain A: W.4792, M.4796, L.4799, Y.4802, N.4803, F.4805, F.4806, A.4808, A.4809
- Chain F: L.4848, V.4851, V.4852, N.4855, F.4856
- Ligands: PCW.13
13 PLIP interactions:4 interactions with chain F, 9 interactions with chain A- Hydrophobic interactions: F:L.4848, F:V.4851, F:V.4852, F:F.4856, A:W.4792, A:L.4799, A:Y.4802, A:F.4805, A:F.4806, A:A.4808, A:A.4809
- Hydrogen bonds: A:Y.4802, A:N.4803
PCW.13: 13 residues within 4Å:- Chain A: Y.4628
- Chain F: L.4848, Y.4849, V.4852, N.4855, F.4856, Y.4907, Y.4910, V.4913, F.4914, T.4917, F.4921
- Ligands: PCW.7
13 PLIP interactions:13 interactions with chain F- Hydrophobic interactions: F:L.4848, F:Y.4849, F:Y.4849, F:Y.4849, F:V.4852, F:F.4856, F:F.4856, F:F.4856, F:Y.4907, F:Y.4910, F:Y.4910, F:V.4913, F:F.4921
PCW.14: 15 residues within 4Å:- Chain F: W.4792, M.4796, L.4799, Y.4802, N.4803, F.4805, F.4806, A.4808, A.4809
- Chain G: L.4848, V.4851, V.4852, N.4855, F.4856
- Ligands: PCW.20
13 PLIP interactions:9 interactions with chain F, 4 interactions with chain G- Hydrophobic interactions: F:W.4792, F:L.4799, F:Y.4802, F:F.4805, F:F.4806, F:A.4808, F:A.4809, G:L.4848, G:V.4851, G:V.4852, G:F.4856
- Hydrogen bonds: F:Y.4802, F:N.4803
PCW.20: 13 residues within 4Å:- Chain F: Y.4628
- Chain G: L.4848, Y.4849, V.4852, N.4855, F.4856, Y.4907, Y.4910, V.4913, F.4914, T.4917, F.4921
- Ligands: PCW.14
13 PLIP interactions:13 interactions with chain G- Hydrophobic interactions: G:L.4848, G:Y.4849, G:Y.4849, G:Y.4849, G:V.4852, G:F.4856, G:F.4856, G:F.4856, G:Y.4907, G:Y.4910, G:Y.4910, G:V.4913, G:F.4921
PCW.21: 15 residues within 4Å:- Chain G: W.4792, M.4796, L.4799, Y.4802, N.4803, F.4805, F.4806, A.4808, A.4809
- Chain H: L.4848, V.4851, V.4852, N.4855, F.4856
- Ligands: PCW.27
13 PLIP interactions:4 interactions with chain H, 9 interactions with chain G- Hydrophobic interactions: H:L.4848, H:V.4851, H:V.4852, H:F.4856, G:W.4792, G:L.4799, G:Y.4802, G:F.4805, G:F.4806, G:A.4808, G:A.4809
- Hydrogen bonds: G:Y.4802, G:N.4803
PCW.27: 13 residues within 4Å:- Chain G: Y.4628
- Chain H: L.4848, Y.4849, V.4852, N.4855, F.4856, Y.4907, Y.4910, V.4913, F.4914, T.4917, F.4921
- Ligands: PCW.21
13 PLIP interactions:13 interactions with chain H- Hydrophobic interactions: H:L.4848, H:Y.4849, H:Y.4849, H:Y.4849, H:V.4852, H:F.4856, H:F.4856, H:F.4856, H:Y.4907, H:Y.4910, H:Y.4910, H:V.4913, H:F.4921
PCW.28: 15 residues within 4Å:- Chain A: L.4848, V.4851, V.4852, N.4855, F.4856
- Chain H: W.4792, M.4796, L.4799, Y.4802, N.4803, F.4805, F.4806, A.4808, A.4809
- Ligands: PCW.6
13 PLIP interactions:4 interactions with chain A, 9 interactions with chain H- Hydrophobic interactions: A:L.4848, A:V.4851, A:V.4852, A:F.4856, H:W.4792, H:L.4799, H:Y.4802, H:F.4805, H:F.4806, H:A.4808, H:A.4809
- Hydrogen bonds: H:Y.4802, H:N.4803
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Weninger, G., Structural basis for statin-induced skeletal muscle weakness. To Be Published
- Release Date
- 2025-10-08
- Peptides
- Ryanodine receptor 1: AFGH
Peptidyl-prolyl cis-trans isomerase FKBP1A: BCDE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AF
BG
CH
DB
EC
FD
GE
H - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 4 x CFF: CAFFEINE(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 4 x CA: CALCIUM ION(Non-covalent)
- 8 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Weninger, G., Structural basis for statin-induced skeletal muscle weakness. To Be Published
- Release Date
- 2025-10-08
- Peptides
- Ryanodine receptor 1: AFGH
Peptidyl-prolyl cis-trans isomerase FKBP1A: BCDE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AF
BG
CH
DB
EC
FD
GE
H - Membrane
-
We predict this structure to be a membrane protein.